NURS 5432 TEST 1 MATERIALS WITH COMPLETE
SOLUTIONS 100% VERIFIED NEWEST
Breast cancer screening per ACS - ANSWER Anual between 45 and 54 years, then every
two years after age 55
Breast Cancer - ANSWER 2nd most cause of CA death in USA women
Malignant neoplasm of cells native to breast epithelial, glandular, or stoma
Hormone replacement therapy is a RISK FACTOR for Breast CA - ANSWER (combination
estrogen-progestrone and estrogen only agent)
during perimenopause increases breast cancer risk for 10 years after medication
discontinued
Treatment for breast CA - ANSWER Hormonal therapy
-SERMS
Tamoxifen (20-40mg daily; if more than 20 use twice daily dose)
Raloxifene (60mg daily)
Calcium and vitamin D supplement is recommended
- non-steroidal aromatase inhibitors {lowers estrogen production}
Anastrozole 1mg daily
Letrozole 2.5mg daily
-chemotherapy
-radiation therapy
PAP smear- ANSWER start at 25year per ACS, HPV every 5 years, cotesting every 5
, years, cytology every 3 years
Breast cancer screening- ANSWER Average risk: if chest radiation therapy before 30
year, genetic mutation of BRCA, family/pt history of CA
40-44yr: have option to start mammogram screening every year
45-54yr: SHOULD get mammogram every year
55 and up: can do every other year or q year until they are in good health to live 10 more
years
high risk: Family history of breast cancer, non-BRCA1 or BRCA2 mutation, head
radiation therapy to chest, LiFraumeni Syndrome, Cowden Syndrome, Banayan-Riley
Ruvalcoba syndrome
Overdiagnosis - ANSWER finding cancer that wouldn't have been a problem if you not
found it
ACS recommend AGAINST MRI if cancer chance is <15%c
cervical dysplasia - ANSWER the growth of abnormal cells in the cervix
can be premalignant cervical disease called cervical intraepithelial neoplasia (CIN)
CIN 1: mild dysplasia with low grade lesion. Cellular change in lower 1/3rd of squamous
epithelium
CIN 2: moderate dysplasia with high grade lesion. Cellular change in lower 2/3 of
squamous epithelium
CIN 3 or Carcinoma in situ: severe dysplasia with high grade lesion. Cellular change in
full thickness of squamous epithelium
-Squamous epithelium increase during pregnancy but reduces postpartum
-Endocervical curettage is contraindicated during pregnancy
SOLUTIONS 100% VERIFIED NEWEST
Breast cancer screening per ACS - ANSWER Anual between 45 and 54 years, then every
two years after age 55
Breast Cancer - ANSWER 2nd most cause of CA death in USA women
Malignant neoplasm of cells native to breast epithelial, glandular, or stoma
Hormone replacement therapy is a RISK FACTOR for Breast CA - ANSWER (combination
estrogen-progestrone and estrogen only agent)
during perimenopause increases breast cancer risk for 10 years after medication
discontinued
Treatment for breast CA - ANSWER Hormonal therapy
-SERMS
Tamoxifen (20-40mg daily; if more than 20 use twice daily dose)
Raloxifene (60mg daily)
Calcium and vitamin D supplement is recommended
- non-steroidal aromatase inhibitors {lowers estrogen production}
Anastrozole 1mg daily
Letrozole 2.5mg daily
-chemotherapy
-radiation therapy
PAP smear- ANSWER start at 25year per ACS, HPV every 5 years, cotesting every 5
, years, cytology every 3 years
Breast cancer screening- ANSWER Average risk: if chest radiation therapy before 30
year, genetic mutation of BRCA, family/pt history of CA
40-44yr: have option to start mammogram screening every year
45-54yr: SHOULD get mammogram every year
55 and up: can do every other year or q year until they are in good health to live 10 more
years
high risk: Family history of breast cancer, non-BRCA1 or BRCA2 mutation, head
radiation therapy to chest, LiFraumeni Syndrome, Cowden Syndrome, Banayan-Riley
Ruvalcoba syndrome
Overdiagnosis - ANSWER finding cancer that wouldn't have been a problem if you not
found it
ACS recommend AGAINST MRI if cancer chance is <15%c
cervical dysplasia - ANSWER the growth of abnormal cells in the cervix
can be premalignant cervical disease called cervical intraepithelial neoplasia (CIN)
CIN 1: mild dysplasia with low grade lesion. Cellular change in lower 1/3rd of squamous
epithelium
CIN 2: moderate dysplasia with high grade lesion. Cellular change in lower 2/3 of
squamous epithelium
CIN 3 or Carcinoma in situ: severe dysplasia with high grade lesion. Cellular change in
full thickness of squamous epithelium
-Squamous epithelium increase during pregnancy but reduces postpartum
-Endocervical curettage is contraindicated during pregnancy
